This novel technology, which expands therapeutic options, offers greater comfort and flexibility to patients' daily activities. It represents a step towards more personalized care, supported by digital technologies aimed at improving clinical outcomes and quality of life.
The procedure combines a patch-type pump with compatible continuous glucose monitoring, without a cable. It automatically adjusts insulin delivery based on the person's glucose levels, promoting better glycemic control and reducing the burden of continuous treatment decisions.
This milestone positions the Ramón y Cajal among reference centers for incorporating advanced diabetes treatment technologies. The treatment is carried out in the Adult Type 1 Diabetes Unit of the Endocrinology and Nutrition Service, directed by Dr. Héctor Escobar Morreale.
The advancement is part of the Community of Madrid's strategy to establish the Ramón y Cajal University Hospital as a Center of Excellence for Endocrine and Metabolic Diseases, integrating clinical care, therapeutic education, prevention, research, and technological innovation.
The Type 1 Diabetes Unit at Ramón y Cajal currently serves approximately 3,000 adult patients with this condition, making it one of the most active and specialized units in the country. It incorporates around 150 new patients annually and conducts over 5,200 consultations.
The multidisciplinary team consists of four specialized endocrinologists, four diabetes educator nurses, two laboratory technicians, and one predoctoral researcher, integrating clinical practice with translational research.
